Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1997-12-12
2000-07-04
Spector, Lorraine
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
5361231, 435 72, 436501, C07H 100
Patent
active
060840927
ABSTRACT:
Methods of isolating .beta.(1-3)-glucan or .beta.(1-3)glucan-containing organisms in a sample, or of detecting the presence of .beta.(1-3)-glucan or .beta.(1-3)-glucan-containing organisms in a sample, utilizing binding agents for .beta.(1-3)-glucan, such as LacCer, GalCer, globotriaosylceramide and asialoganglioside-GM1, are described. Methods of diagnosing fungal infection, by detecting .beta.(1-3)-glucan or .beta.(1-3)-glucan-containing organisms, are also described. Antibodies and kits useful in the methods are also disclosed.
REFERENCES:
patent: 5032401 (1991-07-01), Jamas et al.
patent: 5089479 (1992-02-01), Krivan et al.
patent: 5156948 (1992-10-01), Christensen et al.
patent: 5217715 (1993-06-01), Krivan et al.
patent: 5225330 (1993-07-01), Ginsburg et al.
patent: 5242800 (1993-09-01), Jimenez et al.
patent: 5266461 (1993-11-01), Tanaka
patent: 5386027 (1995-01-01), Krivan et al.
patent: 5389521 (1995-02-01), Krivan et al.
patent: 5389547 (1995-02-01), Tanaka et al.
patent: 5529904 (1996-06-01), Ginsburg et al.
patent: 5550303 (1996-08-01), Tanaka et al.
patent: 5571683 (1996-11-01), Nakajima et al.
Czop, et al., "Perturbation of .beta.-Glucan Receptors on Human Neutrophils Initiates Phagocytosis and Leukotriene B.sub.4 Production," J. Immunol., 141(9):3170-3176 (1988).
G. Abel and J.K. Czop, "Stimulation of Human Monocyte .beta.-Glucan Receptors by Glucan Particles Induces Production of TNF-.alpha. and IL-1.beta.," In. J. Immunopharmac., 14(8):1363-1373 (1992).
Doita, et al., "Effect of Soluble Aminated .beta.-1, 3-D-Polyglucose on Human Monocytes: Stimulation of Cytokine and Prostaglandin E.sub.2 Production but Not Antigen-Presenting Function," J. Leuk. Biol., 49:342-351 (1991).
Cain, et al., "Role of Complement Receptor Type Three and Serum Opsonins in the Neutrophil Response to Yeast," Complement, 4:75-86 (1987).
Gallin, et al., "Comparative Effects of Particulate and Soluble Glucan on Macrophages of C3H/HeN and C3H/HeJ Mice," In. J. Immunopharmac., 14(2):173-183 (1992).
Brunke-Reese and Mackin, "Enhanced Nitric Oxide (NO) Production by Peritoneal Macrophages Isolated from Rats Treated with PGG-glucan, (BETAFECTIN.TM.)," FASEB J., 8:A216, Abstract No. 1244.
Poutsiaka, et al., "Cross-Linking of the .beta.-Glucan Receptor on Human Monocytes Results in Interleukin-1 Receptor Antagonist but not Interleukin-1 Production," Blood, 82(12):3695-3700 (1993).
Wakshull, et al., "Synergistic Stimulation of Myeloid Progenitor Cell Proliferation by a Novel .beta.-Glucan and GM-CSF," J. Cell Biochem. Supl., 18A:22 (1994).
Mackin, et al., "Enhanced Microbicidal Activities of Human Peripheral Blood Monocytes and Neutrophils (PMN) After Pretreatment with PGG-glucan, (BETAFECTIN.TM.)," FASEB J., 8:A488, Abstract No. 2827 (1994).
Diamond, et al., "the I Domain is a Major Recognition Site on the Leukocyte Integrin Mac-1 (CD11b/CD18) for Four Distinct Adhesion Ligands," J. Cell. Biol., 120(4):1031-1043 (1993).
Wakshull, et al., "Characterization PGG-Glucan Binding to a .beta.-Glucan Receptor on Human Leukocytes," FASEB J., 10:A1338, Abstract No. 1954 (1996).
Czop, J.K. and Kay, J., "Isolation and Characterization of .beta.-Glucan Receptors on Human Mononuclear Phagocytes," J. Exp. Med., 173:(6):1511-1520 (1991).
Szabo, et al., "Biochemical Properties of the Ligand-binding 20-kDa Subunit of the .beta.-Glucan Receptors on Human Mononuclear Phagocytes," J. Biol. Chem., 270(5):2145-2151 (1995).
Goldman, R., "Induction of a .beta.-1,3-D-glucan receptor in P388D1 cells treated with retinoic acid or 1,25-dihydroxyvitamin D.sub.3," Immunology, 63(2):319-324 (1988).
Goldman, R., "Characteristics of the .beta.-Glucan Receptor of Murine Macrophages," Exp. Cell. Res., 174(2):481-490 (1988).
Thornton, et al., "Analysis of the Sugar Specificity and Molecular Location of the .beta.-Glucan-Binding Lectin Site of Complement Receptor Type 3 (CD11b/CD18)," J. Immunol., 156(3):1235-1246 (1996).
Konopski, et al., "A Novel Immunomodulator Soluble Aminated .beta.-1,3-D-Glucan: Binding Characteristics to Mouse Peritoneal Macrophages," Biochem. Biophys. Acta, 1221(1):61-65 (1994).
Muller, et al., "Receptor Binding and Internalization of a Water-Soluble (1.div.3)-.beta.-D-Glucan Biologic Response Modifier in Two Monocyte/Macrophage Cell Lines," J. Immunol., 156:3418-3425 (1996).
Engstad and Robertsen, "Specificity of a .beta.-Glucan Receptor on Macrophages from Atlantic Salmon (Salmo salar L.)," Dev. Comp. Immunol., 18(5):397-408 (1994).
Muller, et al., "Functional .beta.-glucan receptor expression by a microglial cell line," Res. Immunol., 145:267-275 (1994).
Czop, et al., "Production and Isolation of Rabbit Anti-Idiotypic Antibodies Directed Against the Human Monocyte Receptor for Yeast .beta.-Glucans," J. Immunol., 145(3):995-1001 (1990).
Bhunia, et al., "Lactosylceramide Stimulates Ras-GTP Loading, Kinases (MEK, Raf), p44 Mitogen-activated Protein Kinase, and c-fos Expression in Human Aortic Smooth Muscle Cells," J. Biol., Chem., 271(18):10660-10666 (1996).
Chatterjee, et al., "Role of lactosylceramide and MAP kinase in the proliferation of proximal tubular cells in human polycystic kidney disease," J. Lipid Research 37:1334-1343 (1996).
Chatterjee, S., "Lactosylceramide stimulates aortic smooth muscle cell proliferation," Biochem. and Biophy. Research Comm., 181(2):554-561 (1992).
Chatterjee, S., "Regulation of synthesis of lactosylceramide in normal and tumor proximal tubular cells," Biochem. Biophys. Acta, 1167:339-344 (1993).
Stevens, et al., "Lactosylceramide in inflammatory bowel disease: a biochemical study," Gut, 29:580-587 (1988).
Lund-Johansen, et al., "Activation of Human Phagocytes Through Carbohydrate Antigens (CD15, Sialyl-CD15, CDw17, and CDw65)," J. Immunol., 148:3221-3229 (19920.
Yamamoto, et al., "Binding Specificity of Lactobacillus to Glycolipids," Biochem. and Biophys. Research Comm., 228:148-152 (1996).
Tsuruoka, et al., "Selection of a Mutant Cell Line Based on Differential Expression of Glycosphingolipid, Utilizing Anti-lactosylceramide Antibody and Complement," J. Biol. Chem., 268(3):2211-2216 (1993).
Baker, et al., "Glycosphingolipid Receptors for Pseudomonas aeruginosa," Infec. Immun., 58(7):2361-2366 (1990).
Fukuda, et al., "Structures of Glycosphingolipids Isolated from Human Granulocytes," J. Biol., Chem., 260(2):1067-1082 (1985).
Stromberg, et al., "Studies on the binding of bacteria to glycolipids-Two species of Propionibacterium apparently recognize separate epitopes on lactose of lactosylceramide," FEBS Letters, 232(1):193-198 (1988).
Symington, F., "CDw17: A Neutrophil Glycolipid Antigen Regulated by Activation," J. Immunol., 142(8):2784-2790 (1989).
Backenson, et al., "Borrelia burgdorferi Shows Specificity of Binding to Glycosphingolipids," Infec. Immun., 63(8):2811-2817 (1995).
Karlsson, Karl-Anders, "Animal Glycosphingolipids as Membrane Attachment Sites for Bacteria," Annu. Rev. Biochem., 58:309-350 (1989).
Jimenez-Lucho, et al., "Cryptococcus neoformans, Candida Albicans, and Other Fungi Bind Specifically to the Glycosphingolipid Lactosycleramide (Gal.beta.1-4Glc.beta.1-1Cer), a Possible Adhesion Receptor for Yeasts," Infec. Immun., 58(7):2085-2090 (1990).
Sandberg, et al., "Putative Glycoprotein and Glycolipid Polymorphonuclear Leukocyte Receptors for the Actinomyces naeslundii WVU45 Fimbrial Lectin," Infec. and Immun., 63(7):2625-2631 (1995).
Chatterjee, et al., "Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues," Glycobiology, 7(1):57-65 (1997).
Janusz, et al., "Isolation of soluble Yeast .beta.-Glucans that Inhibit Human Monocyte Phagocytosis Mediated by .beta.-Glucan Receptors," J. Immunol., 137(10):3270-3276 (1986).
Konopski, et al., "IFN-gamma inhibits internalization of soluble aminated beta-1,3-D-glucan by macrophages and thereby down-regulates the glucan induced release of TNF-alpha and IL-1beta," Chemical Abstracts, 121(13) (Sep. 26, 1994).
Konopski, et al., "A Novel immunomodulator soluble aminated beta-1,3-D-glucan: binding characteristics to mouse peritoneal macrophages," Chemical Abstracts, 120(17) (Apr. 25,
Fisette Leslie W.
Mackin William M.
Wakshull Eric M.
Zimmerman Janet W.
Lazar-Wesley Eliane
Spector Lorraine
The Collaborative Group, Ltd.
LandOfFree
.beta.(1-3)-glucan diagnostic assays does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .beta.(1-3)-glucan diagnostic assays, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta.(1-3)-glucan diagnostic assays will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1487700